Sickle Cell

young african american man in hospital

Risk of death in sickle cell disease

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.

Effort set to help sickle cell patients manage meds

Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients.

blood cells

Transfusions ease strokes for children with sickle cell

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had “silent” strokes.

Levi Watkins Jr. Lecture to feature DeBaun

The Levi Watkins Jr. Lecture will be held Oct. 14, featuring keynote speaker Michael R. DeBaun.

DeBaun’s sickle cell disease research honored

Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease.

Project targets sickle cell disease in Nigeria

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.